Riociguat single -dose study measuring of blood flow in lungs with high blood pressure associated with heart failure

Mise à jour : Il y a 4 ans
Référence : EUCTR2010-018436-41

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

The objective of the present study is to evaluate the acute hemodynamic effects, safety, and pharmacokinetics of Riociguat in patients with PH associated with diastolic heart failure.


Critère d'inclusion

  • Pulmonary hypertension associated with diastolic heart failure